Industry Funding by Itself is Not a Reason for Rating Down Studies for Risk of Bias

J Law Med Ethics. 2024;52(3):701-703. doi: 10.1017/jme.2024.144. Epub 2024 Dec 16.

Abstract

To evaluate how study characteristics and methodological aspects compare based on presence or absence of industry funding, Hughes et al. conducted a systematic survey of randomized controlled trials (RCTs) published in three major medical journals. The authors found industry-funded RCTs were more likely to be blinded, post results on a clinical trials registration database (ClinicalTrials.gov), and accrue high citation counts.1 Conversely, industry-funded trials had smaller sample sizes and more frequently used placebo as the comparator, used a surrogate as their primary outcome, and had positive results.

Keywords: Bias; Conflict of Interest; Industry Funding; Publication Bias; Spin.

Publication types

  • Review

MeSH terms

  • Bias
  • Conflict of Interest
  • Drug Industry* / economics
  • Humans
  • Randomized Controlled Trials as Topic*
  • Research Design
  • Research Support as Topic*